PHARMA SOLUTIONS: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
PHARMA SOLUTIONS
Largest movements
- Receivables within one year -€90,775
down €90,775 (-43.5%), from €208,512 to €117,737
of which Trade receivables: -€87,306
- Tangible fixed assets -€7,653
down €7,653 (-6.0%), from €126,827 to €119,175
of which Land and buildings: -€6,183
- Cash -€5,991
down €5,991 (-13.5%), from €44,331 to €38,340
mainly Other debts (-€189,278)
- Other debts -€189,278
down €189,278 (-54.8%), from €345,465 to €156,187
- Profit (loss) carried forward +€35,832
up €35,832, from -€35,832 to €0
- Reserves +€29,629
new in 2024: €29,629
of which Distributable reserves: +€28,147
- Trade debts +€9,934
up €9,934 (+482%), from €2,059 to €11,993
- Tax, wage and social debts +€9,463
up €9,463 (+2,505%), from €378 to €9,841
- Other operating charges -€50,862
down €50,862 (-94.4%), from €53,861 to €3,000
- Gross operating margin -€17,835
down €17,835 (-18.0%), from €98,961 to €81,126
- Taxes -€4,063
down €4,063 (-100%), from €4,063 to €0
- Financial charges -€1,938
down €1,938 (-27.9%), from €6,950 to €5,012
From the 2023 result to the 2024 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Derived cash bridge
Derived from the 2023 and 2024 balance sheets and the 2024 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2023 | 2024 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €381,500 | €277,081 | -€104,419 | -27.4% |
| Fixed assets | 21/28 | €128,657 | €121,005 | -€7,653 | -5.9% |
| Tangible fixed assets | 22/27 | €126,827 | €119,175 | -€7,653 | -6.0% |
| Land and buildings | 22 | €124,612 | €118,428 | -€6,183 | -5.0% |
| Plant, machinery and equipment | 23 | €810 | €301 | -€509 | -62.8% |
| Furniture and vehicles | 24 | €1,406 | €445 | -€961 | -68.3% |
| Financial fixed assets | 28 | €1,830 | €1,830 | = | 0.0% |
| Current assets | 29/58 | €252,843 | €156,076 | -€96,766 | -38.3% |
| Amounts receivable within one year | 40/41 | €208,512 | €117,737 | -€90,775 | -43.5% |
| Trade receivables | 40 | €201,312 | €114,006 | -€87,306 | -43.4% |
| Other amounts receivable | 41 | €7,200 | €3,731 | -€3,469 | -48.2% |
| Cash at bank and in hand | 54/58 | €44,331 | €38,340 | -€5,991 | -13.5% |
| Total equity and liabilities | 10/49 | €381,500 | €277,081 | -€104,419 | -27.4% |
| Equity | 10/15 | €33,599 | €99,060 | +€65,461 | +195% |
| Contributions | 10/11 | €61,500 | €61,500 | = | 0.0% |
| Capital | 10 | €61,500 | €61,500 | = | 0.0% |
| Issued capital | 100 | €61,500 | €61,500 | = | 0.0% |
| Revaluation surpluses | 12 | €7,931 | €7,931 | = | 0.0% |
| Reserves | 13 | - | €29,629 | +€29,629 | |
| Non-distributable reserves | 130/1 | - | €1,481 | +€1,481 | |
| Legal reserve | 130 | - | €1,481 | +€1,481 | |
| Distributable reserves | 133 | - | €28,147 | +€28,147 | |
| Profit (loss) carried forward | 14 | -€35,832 | €0 | +€35,832 | |
| Amounts payable | 17/49 | €347,901 | €178,021 | -€169,880 | -48.8% |
| Amounts payable within one year | 42/48 | €347,901 | €178,021 | -€169,880 | -48.8% |
| Trade debts | 44 | €2,059 | €11,993 | +€9,934 | +482% |
| Suppliers | 440/4 | €2,059 | €11,993 | +€9,934 | +482% |
| Taxes, remuneration and social security | 45 | €378 | €9,841 | +€9,463 | +2,505% |
| Taxes | 450/3 | €378 | €9,841 | +€9,463 | +2,505% |
| Other amounts payable | 47/48 | €345,465 | €156,187 | -€189,278 | -54.8% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €8,103 | €7,653 | -€450 | -5.6% |
| Other operating charges | 640/8 | €53,861 | €3,000 | -€50,862 | -94.4% |
| Gross operating margin | 9900 | €98,961 | €81,126 | -€17,835 | -18.0% |
| Operating profit (loss) | 9901 | €36,997 | €70,473 | +€33,477 | +90.5% |
| Financial income | 75/76B | €0 | - | = | |
| Recurring financial income | 75 | €0 | - | = | |
| Financial charges | 65/66B | €6,950 | €5,012 | -€1,938 | -27.9% |
| Recurring financial charges | 65 | €6,950 | €5,012 | -€1,938 | -27.9% |
| Profit (loss) for the period before taxes | 9903 | €30,047 | €65,461 | +€35,415 | +118% |
| Income taxes | 67/77 | €4,063 | €0 | -€4,063 | -100% |
| Profit (loss) for the period | 9904 | €25,984 | €65,461 | +€39,477 | +152% |
| Profit (loss) for the period to be appropriated | 9905 | €25,984 | €65,461 | +€39,477 | +152% |
Source: filed annual accounts (NBB), financial years ended 31 December 2023 and 31 December 2024. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 20 October 2026 via checked.be.